Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss


Pasritamig combination delivers 73% PSA response rate in advanced prostate cancer Phase I study


mNEXSPIKE associated with lower COVID-19 hospitalisation risk than Comirnaty in older adults


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Towards Real Time Release testing: Dissolution prediction of tablets made using Continuous Direct Compression

Presented by Pallavi Pawar of GlaxoSmithKline
21st November 2017


Overcoming Downstream Bottlenecks In The Upscaling Process

Presented by Dr. Dakshesh Mehta, Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division, Wockhardt Research Center
17th January 2019


Risk Assessment of Extractables and Leachables in Different Phases of Development.

Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Ward d’Autry, Study Director E/L & Structural Elucidation, Nelson Labs Europe
22nd April 2021


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia